Deavers MT - Search Results

1

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK. Landen CN Jr, et al. Among authors: deavers mt. Cancer Res. 2005 Aug 1;65(15):6910-8. doi: 10.1158/0008-5472.CAN-05-0530. Cancer Res. 2005. PMID: 16061675

2

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC Jr, Mills GB, Silva EG. Gershenson DM, et al. Clin Cancer Res. 1999 Dec;5(12):4053-8. Clin Cancer Res. 1999. PMID: 10632339

3

The expression of decorin in human ovarian tumors.

Nash MA, Deavers MT, Freedman RS. Nash MA, et al. Among authors: deavers mt. Clin Cancer Res. 2002 Jun;8(6):1754-60. Clin Cancer Res. 2002. PMID: 12060613

4

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.

Verschraegen CF, Hu W, Du Y, Mendoza J, Early J, Deavers M, Freedman RS, Bast RC Jr, Kudelka AP, Kavanagh JJ, Giovanella BC. Verschraegen CF, et al. Clin Cancer Res. 2003 Feb;9(2):845-52. Clin Cancer Res. 2003. PMID: 12576458

5

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Lee CM, et al. Among authors: deavers mt. Gynecol Oncol. 2003 Mar;88(3):363-8. doi: 10.1016/s0090-8258(02)00015-x. Gynecol Oncol. 2003. PMID: 12648588

6

Overexpression of kallikrein 10 in epithelial ovarian carcinomas.

Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford S, Wolf JK, Mills GB, Bast RC Jr, Gershenson DM, Schmandt R. Shvartsman HS, et al. Among authors: deavers mt. Gynecol Oncol. 2003 Jul;90(1):44-50. doi: 10.1016/s0090-8258(03)00257-9. Gynecol Oncol. 2003. PMID: 12821340

7

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

8

Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.

Rosen DG, Yang G, Deavers MT, Malpica A, Kavanagh JJ, Mills GB, Liu J. Rosen DG, et al. Among authors: deavers mt. Cancer. 2006 May 1;106(9):1925-32. doi: 10.1002/cncr.21767. Cancer. 2006. PMID: 16568440 Free article.

9

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.

Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DC. Gershenson DM, et al. Among authors: deavers mt. Obstet Gynecol. 2006 Aug;108(2):361-8. doi: 10.1097/01.AOG.0000227787.24587.d1. Obstet Gynecol. 2006. PMID: 16880307

10

Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.

Merritt WM, Thaker PH, Landen CN Jr, Deavers MT, Fletcher MS, Lin YG, Han LY, Kamat AA, Schmandt R, Gershenson DM, Kinch MS, Sood AK. Merritt WM, et al. Among authors: deavers mt. Cancer Biol Ther. 2006 Oct;5(10):1357-60. doi: 10.4161/cbt.5.10.3225. Epub 2006 Oct 31. Cancer Biol Ther. 2006. PMID: 16969087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page